Cybg (LON:CYBG) Rating Reiterated by Barclays
Several other equities research analysts also recently commented on the stock. UBS Group raised shares of to a neutral rating and boosted their target price for the stock from GBX 945 ($12.35) to GBX 2,060 ($26.92) in a research report on Thursday, June 20th. Jefferies Financial Group decreased their target price on shares of Seres Therapeutics from $6.00 to $4.00 and set a hold rating for the company in a research report on Monday, July 1st. Citigroup boosted their target price on shares of from GBX 1,300 ($16.99) to GBX 1,450 ($18.95) and gave the stock a buy rating in a research report on Friday, June 21st. Shore Capital reissued a hold rating on shares of in a research report on Wednesday, June 19th. Finally, Investec downgraded shares of Cybg to a hold rating and set a GBX 230 ($3.01) target price for the company. in a research report on Monday, April 15th. Nine analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of Hold and an average price target of GBX 243.46 ($3.18).
LON:CYBG opened at GBX 196.80 ($2.57) on Wednesday. The stock’s 50-day simple moving average is GBX 190.86. The company has a market capitalization of $2.82 billion and a P/E ratio of -27.72. Cybg has a one year low of GBX 172.10 ($2.25) and a one year high of GBX 367 ($4.80).
CYBG PLC, through its subsidiaries, provides retail and business banking products and services to individuals and businesses under the Clydesdale Bank, Yorkshire Bank, B, and Virgin Money brands in the United Kingdom. It operates through SME Banking and Retail Banking segments. The SME Banking segment offers a range of banking products and services, including business current accounts; and secured and unsecured term loans, business overdrafts, and invoice and asset financing products and services.
Read More: What is cost of equity?
Receive News & Ratings for Cybg Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybg and related companies with MarketBeat.com's FREE daily email newsletter.